GLOMERULOPATHY Clinical Trials

8 clinical trials for GLOMERULOPATHY across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. — RECRUITING · PHASE3
• Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center — RECRUITING
• AN OPEN-LABEL, NON-RANDOMIZED EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY, SAFETY AND TOLERABILITY OF IPTACOPAN (LNP023) IN C3 GLOMERULOPATHY OR IDIOPATHIC IMMUNE-COMPLEX-MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS — RECRUITING
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF IPTACOPAN (LNP023) IN COMPLEMENT 3 GLOMERULOPATHY — RECRUITING
• Dietary Intervention in Obesity-related Glomerulopathy — OTHER · NA
• A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN PATIENTS WITH C3 GLOMERULOPATHY OR IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS — COMPLETED · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF AVACOPAN (CCX168) IN PATIENTS WITH C3 GLOMERULOPATHY — COMPLETED · PHASE2
• Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease — TERMINATED · PHASE4

Refine this search